Christopher Yea - 11 Jan 2023 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Chief Development Officer
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
11 Jan 2023
Net transactions value
-$26,416
Form type
4
Filing time
19 May 2023, 21:20:00 UTC
Previous filing
21 Nov 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Options Exercise +4,205 +12% 39,914 17 May 2023 Direct F1
transaction KALV Common Stock Sale $26,416 -2,604 -6.5% $10.14 37,310 18 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Restricted Stock Unit Award $0 +29,166 $0.000000 29,166 11 Jan 2023 Common Stock 29,166 Direct F1, F3
transaction KALV Restricted Stock Unit Options Exercise $0 -2,431 -9.1% $0.000000 24,305 17 May 2023 Common Stock 2,431 Direct F1, F3
transaction KALV Restricted Stock Unit Options Exercise $0 -1,774 -7.7% $0.000000 21,285 17 May 2023 Common Stock 1,774 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 1/12th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on November 17, 2022, for a period of three years, subject to continued service through each vesting date.
F4 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 17, 2022, subject to continued service through each vesting date.